BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20487892)

  • 1. Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg(6)-Phe(7) degradation by rat striatal synaptosomal membranes.
    Benuck M; Berg MJ; Marks N
    Neurochem Int; 1982; 4(5):389-96. PubMed ID: 20487892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of a heptapeptide opioid by rat brain and cardiac tissue.
    Marks N; Benuck M; Berg MJ
    Life Sci; 1982 Oct 18-25; 31(16-17):1845-8. PubMed ID: 7154837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of proenkephalin-derived opioid peptides from rat striatum in vitro and their rapid degradation.
    Patey G; Cupo A; Mazarguil H; Morgat JL; Rossier J
    Neuroscience; 1985 Aug; 15(4):1035-44. PubMed ID: 4047398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    Gillespie MN; Krechniak JW; Crooks PA; Altiere RJ; Olson JW
    J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of the heptapeptide Met-enkephalin-Arg6-Phe7 and of the octapeptide Met-enkephalin-Arg6-Gly7-Leu8 from rat striatum in vitro and their rapid inactivation.
    Patey G; Cupo A; Chaminade M; Morgat JL; Rossier J
    Life Sci; 1983; 33 Suppl 1():117-20. PubMed ID: 6664213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8.
    Acker GR; Molineaux C; Orlowski M
    J Neurochem; 1987 Jan; 48(1):284-92. PubMed ID: 2878974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan.
    Hiranuma T; Oka T
    Jpn J Pharmacol; 1986 Aug; 41(4):437-46. PubMed ID: 3534399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and biochemical evidence for the presence of the pentapeptide met-enkephalin and the heptapeptide met-enkephalin-Arg(6)-Phe(7) but not the octapeptide met-enkephalin-Arg(6)-Gly(7)-Leu(8) in amphibian chromaffin cells.
    Leboulenger F; Cupo A; Castanas E; Benyamina M; Pelletier G; Vaudry H
    Neurochem Int; 1986; 8(3):303-9. PubMed ID: 20493060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain.
    Cushman DW; Gordon EM; Wang FL; Cheung HS; Tung R; Delaney NG
    Life Sci; 1983; 33 Suppl 1():25-8. PubMed ID: 6319870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of Met-enkephalin-Arg6-Phe7 by a purified brain carboxypeptidase (cathepsin A).
    Marks N; Sachs L; Stern F
    Peptides; 1981; 2(2):159-64. PubMed ID: 7291041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain.
    Norman JA; Autry WL; Barbaz BS
    Mol Pharmacol; 1985 Dec; 28(6):521-6. PubMed ID: 3001497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic conversion of [Met]enkephalin-Arg6-Gly7-Leu8 by brain synaptic membranes. Characterization of formed peptides and mechanism of proteolysis.
    Norman JA; Chang JY
    J Biol Chem; 1985 Mar; 260(5):2653-6. PubMed ID: 2982830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the thiorphan-sensitive endopeptidase, termed enkephalinase A, on glial cells.
    Lentzen H; Palenker J
    FEBS Lett; 1983 Mar; 153(1):93-7. PubMed ID: 6337881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state level and turnover rate of the tripeptide Tyr-Gly-Gly as indexes of striatal enkephalin release in vivo and their reduction during pentobarbital anesthesia.
    Llorens-Cortes C; Gros C; Schwartz JC
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6226-30. PubMed ID: 3526354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations.
    Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL
    Regul Pept; 1991 Feb; 32(3):267-78. PubMed ID: 1678195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enkephalin degradation by enkephalinergic neuroblastoma cells. Involvement of angiotensin-converting-enzyme.
    Palenker J; Lentzen H; Brandt U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):214-7. PubMed ID: 6328331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enkephalin-containing polypeptides are potent inhibitors of enkephalin degradation.
    Hui KS; Hui M; Banay-Schwartz M; DeGuzman T; Ling N; Lajtha A
    Peptides; 1983; 4(5):639-46. PubMed ID: 6657512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.